期刊
JOURNAL OF IMMUNOLOGY
卷 185, 期 7, 页码 3970-3979出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0903269
关键词
-
类别
资金
- Associazione Italiana Ricerca sul Cancro (Milan)
- Compagnia di San Paolo (Torino)
- Fondazione Cassa di Risparmio di Torino
- Alfieri Project (Torino)
- Regione Piemonte (Ricerca Sanitaria Finalizzata and Piattaforme Innovative)
- Fondazione Italiana Sclerosi Multipla (Genoa) [2008/R/711]
- Fondazione Amici di Jean (Torino)
- University of Torino
Vascular endothelial cells (ECs) are key players in leukocyte recruitment into tissues and metastatic dissemination of tumor cells. ECs express B7h, which is the ligand of the ICOS T cell costimulatory molecule. The aim of this work was to assess the effect of B7h triggering by a soluble form of ICOS (ICOS-Fc) on the adhesion of colon carcinoma cell lines to HUVECs. We found that B7h triggering inhibited HUVEC adhesiveness to HT29 and DLD1 cells (by 50 and 35%, respectively) but not to HCT116 cells. The effect was dependent on the ICOS-Fc dose and was detectable as early as 30 min after treatment and was still present after 24 h. It was inhibited by soluble anti-ICOS reagents (mAb and B7h-Fc) and silencing of B7h on HUVECs, and it was not displayed by an F119S mutated form of ICOS-Fc that does not bind B7h. HUVEC treatment with ICOS-Fc did not modulate expression of adhesion molecules and cytokines, but it substantially downmodulated ERK phosphorylation induced by E-selectin triggering or osteopontin, which may influence HUVEC adhesiveness. Moreover, HUVEC treatment with ICOS-Fc also inhibited adhesion of polymorphonuclear cells and several tumor cell lines from different origins. Therefore, the B7h-ICOS interaction may modulate spreading of cancer metastases and recruitment of polymorphonuclear cells in inflammatory sites, which opens a view on the use of ICOS-Fc as an immunomodulatory drug. The Journal of Immunology, 2010, 185: 3970-3979.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据